{"href":"https://api.simplecast.com/oembed?url=https%3A%2F%2Foperations-utopia.simplecast.com%2Fepisodes%2F05-nuno-valerio-9hFQT6RV","width":444,"version":"1.0","type":"rich","title":"05 | Trust Architecture: Rethinking Validation for a Probabilistic World — with Nuno Valério","thumbnail_width":300,"thumbnail_url":"https://image.simplecastcdn.com/images/df950f79-0fa8-4033-ad58-536486f0ec84/b26b99de-b0dc-4c95-b860-ed0ef11d180c/image_7.jpg","thumbnail_height":300,"provider_url":"https://simplecast.com","provider_name":"Simplecast","html":"<iframe src=\"https://player.simplecast.com/37082a62-b591-40b7-b114-531fd7b46005\" height=\"200\" width=\"100%\" title=\"05 | Trust Architecture: Rethinking Validation for a Probabilistic World — with Nuno Valério\" frameborder=\"0\" scrolling=\"no\"></iframe>","height":200,"description":"Nuno Valério is Head of Innovation, R&D Quality at Merck, based in Germany. With 11+ years in pharma quality across deviations, audits, and observations, plus an active public-facing practice on AI governance, Nuno has become a distinctive voice on what trustworthy AI looks like inside a regulated R&D organization.\n\nHe writes and speaks regularly on a framework he calls trust architecture — a multi-dimensional approach to validating not the model itself but the workflow, guardrails, and human-machine ecosystem around it. He's a featured speaker at the 2026 Clinical Trial Innovation Summit in Basel, where his session focuses on designing AI governance from both sides of the wall — pharma and regulator — drawing on his hands-on work at Merck."}